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T-cell infiltration into human cancer tissues can be a manifestation of host immune responses to cancer cells. The present study was
undertaken to explore the clinicopathological significance of intraepithelial CD8
þ T cells using 371 consecutively sampled human
colorectal carcinomas. By univariate analysis, we noted that the survival curves by intraepithelial CD8
þ T cells became separated only
after 1 to 2 years postoperation. Multivariate analyses revealed that the beneficial effect of this factor becomes significant only after a
longer (more than 2 year), but not after a shorter (less than 2 year) follow-up period. Furthermore, the number of intraepithelial
CD8
þ T cells was significantly higher in patients alive for more than 5 years than in patients who either died of cancer after a curative
operation or patients who underwent a noncurative operation. Patients’ cancer-specific death long after a curative operation is
thought to be caused by the growth of micrometastases in other organs or near the primary sites. The effects of intraepithelial CD8
þ
T cells, therefore, may be mediated by suppression of micrometastasis, rather than suppression of growth in the primary tumour. In
conclusion, our data support a hypothesis on the presence of systemic immunosurveillance against micrometastasis of cancer cells.
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After considerable controversy, recent studies have supported the
hypothesis that the presence of immunosurveillance has an effect on
tumour development (Smyth et al,2 0 0 1 ;D u n net al, 2002). Para-
neoplastic syndromes associated with degeneration of nervous tissues
are now regarded as a manifestation of effective antitumour immune
responses against neuronal antigens expressed by tumour cells (Albert
and Darnell, 2004). Tumour-associated antigens recognised by T cells
have been reported, and therapeutic trials utilizing tumour vaccines
are now ongoing (Henderson and Finn, 1996; Melief et al, 2000;
Rosenberg 2001). On the other hand, tumour cells protect themselves
from the host’s surveillance by utilizing various immune evasion
mechanisms (Khong and Restifo, 2002). Thus, immunocompetent and
cancer cells interact mutually forming a complex relationship.
As for colorectal cancer, Naito et al (1998) have pointed out in a
study of 131 patients that the number of intraepithelial CD8
þ T
cells (designated as CD8
þT cells within cancer cell nests in this
paper) has a more significant impact on patients’ survival than that
of CD8
þ T cells in other locations within the tumour. Recently,
Menon et al (2004) pointed out that CD8
þ and CD57
þ cells along
the invasive margin have a significant impact on better disease-free
survival in patients with colorectal cancer in a study of 93 patients.
CD8
þ T cells distributed among cancer cells or along the invasive
margin are positively associated with apoptosis of cancer cells in
hepatocellular (Fukuzawa et al, 2001) and oesophageal carcinomas
(Schumacher et al, 2001). Various immune cell responses in
ovarian carcinomas at stages III and IV are also associated with
better prognosis (Zhang et al, 2003). In renal cell carcinoma,
however, Nakano et al (2001) clearly showed that intratumoral
CD8
þ T cells (defined as CD8
þT cells among cancer cells or
those in contact with cancer cells), as well as CD8
þ or CD4
þ
lymphocytes in other cancer locations, were positively correlated
with the biological malignancy of cancer, associating lymphocyte
responses with a poor prognosis. Furthermore, 10–20% of human
colorectal carcinoma is associated with microsattelite instability
(MSI), and cases with MSI are characterised by more frequent
infiltration by lymphocytes, increased rate of apoptotic cancer
cells, and better survival than cases with microsatellite stability
(MSS) (Jass et al, 1995; Dolcetti et al, 1999; Michael-Robinson et al,
2001; Ishikawa et al, 2003). These complexities led us to revisit our
previous analyses in a larger-scale study. Here we show that the
effects of intraepithelial CD8
þ T cells become manifest after longer
follow-up periods, allowing us to speculate that host immune
responses represented by local CD8
þ T-cell infiltration may
actually contribute to the patients’ prognosis by suppressing
micrometastases.
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Patients (Table 1)
The present study is a retrospective study using a total of 371 cases
of colorectal carcinoma including all stages, which were consecu-
tively sampled from Tohoku Rosai Hospital (Sendai), Tohoku
University Hospital (Sendai), and Miyagi Cancer Center Hospital
(Natori). All cases underwent resection of the primary tumour.
Cases with macroscopic or microscopic residue of tumour cells at
the surgical margins and those with preoperative chemo- or
irradiation therapy were excluded. The average age was 63.2 years
(s.d. 11.3), ranging from 28 to 88, male to female ratio 214:157.
The average follow-up period of surviving patients was 2674 days
(7.7 years) with an s.d. of 1403 days. All cases were histopatho-
logically diagnosed according to the WHO classification (Hamilton
and Aaltonen, 2000) and TNM staging (Sobin and Wittekind,
2002). The number of cases of TNM stages I, II, III, and IV,
corresponding to Dukes A, B, C, and D, were 51, 137, 136, and 47,
respectively. Lymph node metastases were checked by histopatho-
logical examination in all cases. Distant metastases were diagnosed
by either CT scanning or histopathological examination. ‘Curative
operation’ here means that the patient has no clinically detectable
reside or metastasis at the time of surgical resection of the primary
tumour. Cancer-specific death was recorded in 74 cases in this
group.
Histopathology and immunohistochemistry
Formalin-fixed, paraffin-embedded sections were used. For
immunohistochemistry, we used the following primary antibodies:
anti-CD8 (clone C8/144B, Dakocytomation Japan, Kyoto, Japan),
anti-hMLH1, and anti-hMSH2. After deparaffinisation, sections
were pretreated by autoclave heating for 5min. Dextran-polymer
method with EnVison plus (Dako) was used as the secondary
antibody.
Methods of cell counting
Intraepithelial CD8
þ T cells were defined as CD8
þ T cells located
within cancer cell nests, not including those in the stroma, and
their distribution was quantified as described previously (Nakano
et al, 2001). In brief, we first observed the whole area of specimens
to select three areas with the most abundant infiltration of
intraepithelial CD8
þ T cells. Areas near necrosis were excluded.
Cell counting was performed using an ocular grid at  200
magnification. All the counting was carried out by two indepen-
dent observers, and the correlation coefficiency between the data
obtained by the two observers was 0.96.
Statistical analyses
The impact on the cancer-specific survival rate was tested by uni-
and multivariate analyses with SPSS 11.0J. (SPSS Japan Inc.,
Tokyo, Japan). The observation periods were divided at 2 years in
the multivariate analyses, because the number of patients who died
of the primary disease became equal with this dichotomy.
Double-labelling immunohistochemisty for CD8 and Ki-67
The method was described previously (Naito et al, 1998). The
labelling index for Ki-67 in CD8þ T cells was obtained by the ratio
of the number of double positive cells per the sum of number of
single CD8þ T cells and that of double positive cells
RESULTS
Figure 1A shows one of the cases of colorectal carcinoma
showing the median number of intraepithelial CD8
þ T cells. The
distribution of the number of T cells was quite asymmetric
(Figure 2A). Some cases showed abundant intraepithelial CD8
þ
T cells as exemplified in Figure 1B, but such cases were quite
infrequent. For the statistical analyses we divided the patients into
two groups at the median number. Univariate analysis in all 371
cases revealed that intraepithelial CD8
þ T cells (Figure 2B) and
peritumoral tumour-infiltrating lymphocytes (TILs), together with
stage and invasion pattern, were significant for cancer-specific
survival (Table 2). Histologic differentiation, age, gender, site of
the primary tumour, or abnormality in mismatch repair proteins
were not significant. The number of intraepithelial CD8
þ T cells
inversely correlated with the stage (Figure 2C), and it was mildly
higher in the right-sided colon than in the left-sided colon or
rectum without statistical significance (P¼0.43 by Kruskal–Wallis
test). The lack of the expression of mismatch repair proteins was
detected in 36 of 366 cases. Five cases were excluded due to lack of
reactivity for MMR proteins in non-neoplastic cells. This lack was
not associated with a significant increase in the number of
intraepithelial T cells (P¼0.21 by Mann–Whitney test). The
number of intratumoral CD8
þ T cells positively correlated with
peritumoral TILs (g¼0.35, Po0.01).
Closer inspection of survival curves by the number of
intraepithelial CD8
þ T cells (divided at the median) revealed a
distinctive feature: the two curves were nearly the same during the
first 1 year, and became gradually differentiated after 2 years
postoperation (Figure 2B). To further analyse this feature, we
compared the results of multivariate analyses set at different
observation periods. As shown in Table 3 (upper part), the number
of intraepithelial CD8
þ T cells was significant for patients’ survival
at the 5-year observation periods both in all patients, and in the
curative operation group by a logistic model. Other parameters
significant included stage-related parameters (lymph node and
distant metastases) and invasion pattern. The impact (Odds ratio)
of intraepithelial CD8
þ T cells was smaller than that of stage-
related factors, which may be caused by the negative correlation
with stage (Figure 2C). We also checked the impact of the number
of these T cells at other dichotomy points including 70, 75, and 80
percentile values, with none of them being significant (data not
shown). In contrast to this, the number of intraepithelial CD8
þ
Table 1 Peritumoral TILs defined as mononuclear cell infiltrate along the invasive margin
Age Gender Stage Site Invasion
a
Peritumoral
TILs
a Differentiation
Mean 63.2 Male 214 I 51 Right-sided
colon
117 Expanding 211 Continuous 60 Poorly
differentiated
22
s.d. 11.3 Female 157 II 137 Left-sided
colon
113 Infiltrating 160 Others 311 Others 349
Median 63 III 136 Rectum 141
IV 47
aDefined as Jass et al (1987).
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logistic model (Table 3, lower part).
Analyses by Cox proportional hazards models also revealed the
same results: the number of these CD8
þ T cells was significant for
patients’ survival only when the observation period was set at 2–10
years after operation, but not at 0–2 years in both all patients’- and
curative operation groups (Table 4). These data clearly indicated
that the effects of intraepithelial CD8
þ T cells became evident only
through a longer follow-up period.
To check the above-mentioned results from a different angle, we
compared the number of intraepithelial CD8
þ T cells among
patients who were alive for more than 5 years after a curative
operation (group A, 122 cases – stage I excluded due to its low
mortality), patients who died of the primary disease after a
curative operation (group B, 72 cases), and patients who died of
the primary disease after non-curative operation (group C, 63
cases). As shown in Figure 3, the number of intraepithelial CD8
þ T
cells in group A was significantly higher than those in groups B
and C, without any significant differences between groups B and C.
These data were consistent with the notion that intraepithelial
CD8
þ T cells are a prognostic factor, and further suggested that
the decrease of these T cells in stage IV may not be a consequence
of systemic immunosuppression by widely spread cancer (for
details, see Discussion).
We next estimated the proliferative activity of T cells by their
labelling index for Ki-67 by double-labelling immunohistochem-
istry (Figure 4A), and compared this between intraepithelial- and
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Figure 2 Distribution histogram of the number of intraepithelial CD8
þ
T cells in colorectal carcinoma (A), showing a distinct asymmetric pattern.
Cancer-specific survival curves by intraepithelial CD8
þ T cells in all patients
(divided into two at the median) (B). The longitudinal axis, cancer-specific
cumulative survival rate. The horizontal axis, years after operation. Note an
inverse correlation between the number of intraepithelial CD8
þ T cells
and the stages (C), depicted by Box–Whisker plot showing 25 percentile,
median, and 75 percentile.
Median
Highly abundant
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B
Figure 1 Immunohistochemical results. Cases with median (A) and
highly abundant (B) intraepithelial CD8
þ T cells in colorectal carcinoma.
Scale bar, 50mm.
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þ T cells in 21 representative cases of well or
moderately differentiated adenocarcinoma, of which only one case
showed the lack of MMR proteins. Peritumoral T cells refers to
T cells located along the invasive margin, which were usually more
abundant than intraepithelial T cells (Ohtani et al, 1997). As shown
in Figure 4B, intraepithelial CD8
þ T cells showed a much higher
labelling index for Ki-67 (7% in median) than peritumoral CD8
þ
T cells did (1% in median), indicating presumable tumour-specific
reactivity of intraepithelial T cells.
Table 3 Results of multivariate analyses by logistic model at 5- and 2-year observation periods
5-year observation period
All patients (N¼295) Curative operation group (N¼233)
Parameters (risk factor) Odds ratio 95% CI P Parameters Odds ratio 95% CI P
Lymph node metastasis
a
(positive)
8.3 4.3–16 o0.0005 Lymph node metastasis
a 5.9 3.0–12 o0.0005
Distant metastasis
a
(positive)
230 29–1800 o0.0005 Invasion pattern 3.3 1.6–6.5 0.001
Invasion pattern
(infiltrating)
3.2 1.6–6.0 0.001 Intraepithelial CD8
+ T cells 2.4 1.2–4.8 0.011
Intraepithelial CD8
+ T cells (low) 2.3 1.2–4.3 0.01
Parameters not significant
b: peritumoral TILs (P¼0.25, 0.24), differentiation (P¼0.47, 0.79), site (P¼0.86, 0.78), MMR proteins (P¼0.99, 0.81), age (P¼0.20, 0.26),
gender (P¼0.77, 0.69), invasion to subserosa
a (P¼0.37, 0.41)
2-year observation period
All patients (N¼348) Curative operation group (N¼290)
Parameters Odds ratio 95% CI P Parameters Odds ratio 95% CI P
Lymph node metastasis
a 4.3 1.9–9.9 o0.0005 Lymph node metastasis
a 2.4 0.98–5.6 0.056
Distant metastasis
a 55 19–158 o0.0005 Invasion pattern 11 3.5–32 o0.0005
Invasion pattern 7.2 3.4–15 o0.0005
Parameters not significant
b: intraepithelial CD8+ T cells (P¼0.28, 0.63), differentiation (P¼0.45, 0.87), peritumoral TILs (P¼0.10, 0.22), site (P¼0.64, 0.55), MMR
proteins (P¼0.38, 0.65), age (P¼0.33, 0.71), gender (P¼0.67, 0.79)
Note that intraepithelial CD8+ T cell was not significant at 2-year follow-up period. 95% CI¼95% confidence interval of Odds ratio. Death of the primary cancer defined as the
event. Bold face¼parameters significant for patients’ survival after stepdown parameter selection analysis. Italic values stress intraepithelial CD8+ T cells. Data input as follows:
Lymph node and distant metastases, negative 1 and positive 2; invasion, expanding 1 and infiltrating 2; CD8, high 1 and low 2; TILs, continuous 1 and not continuous 2;
differentiation, not poorly 1 and poorly 2; MMR, normal 1 and lack 2; site, rectum 1, left 2 and right 3; gender, male 1 and female 2; age younger 1 and elder 2. CD8 divided at the
median, lower 1 and higher 2. Invasion to subserosa, negative 1 and positive 2.
aAnalysed in comparison with stage 1.
bP-values in the parentheses: The former for all patients and
the latter for curative operation group.
Table 2 Results of univariate analysis
P-value (log-rank test)
Parameters Risk factor All patients
Curative
operation
group
Stage More advanced stage o0.00005 o0.00005
Invasion pattern Infiltrating pattern o0.00005 o0.00005
Intraepithelial
CD8+ T cells
Low o0.00005 o0.00005
Peritumoral TILs Not conspicuous o0.00005 0.0002
Differentiation (Poor differentiation) 0.066 0.97
MMR proteins (No abnormality) 0.17 0.083
Site (Rectum) 0.35 0.1
Age 0.68 0.93
Gender 0.97 0.95
Bold face parameters significant for cancer-specific survival. MMR proteins, mismatch
repair proteins (hMLH1 and hMSH2).
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Figure 3 Morphometric results of the number of intraepithelial CD8
þ T
cells among different groups. The longitudinal axis, the number of
intraepithelial CD8
þ T cells. A, Patients alive for more than 5 years (stage
I excluded). B, Patients who died of the primary disease after curative
operation (stages II and III). C, patients who received noncurative operation
(stage IVþstage III with unresectable lymph node metastasis). We
excluded cases positive for cancer cells at the resection margins. Overall
differences, Po0.0005 (Kruskal–Wallis).
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The present paper confirmed that the number of intraepithelial
CD8
þ T cells, counted at the most densely distributed areas, was
an independent prognostic factor in colorectal cancer in a larger-
scale study (371 patients), and that this effect was most evident
when the patients were divided into two groups at the median
number of these T cells. Of particular importance, we newly
demonstrated that the effects of these immune cell factors became
manifest only after a long follow-up period.
First, it is necessary to summarise why we focused on
intraepithelial CD8
þ T cells. We initially observed Epstein–Barr
virus-associated gastric cancer to find an abundance of intraepithe-
lial CD8
þ T cells (Saiki et al, 1996). We then revealed that
intraepithelial T cells (¼T cells within cancer cell nests) in
colorectal cancer had the most significant impact on patients’
survival than those in other locations (Naito et al, 1998). The present
study at an early stage (200 cases) also confirmed that the number of
peritumoral CD8
þ T cells was not significant for patients’ survival
by multivariate analysis (Naito et al, unpublished data). Also, the
number of peritumoral CD68
þ macrophages and that of peritu-
moral neutrophils were not significant even under univariate
analysis (Naito et al, unpublished data). Therefore, we focused on
intraepithelial CD8
þ T cells in the present study (371 cases).
The main causes of death after curative operation are
metachronous metastases in distant organs, lymph nodes, or
peritoneal cavity and recurrence at the primary site. These
ominous consequences are generally caused by the growth of
micrometastases that were considered to be present at the time
of operation. So long as we assume that intraepithelial CD8
þ
T cells attack tumour cells only at the primary site, our results
are difficult to explain, because our data showed that the
patients’ survival was affected by the degree of T-cell responses
in the resected primary tumour. Thus, other explanations are
required. Here we hypothesise effective suppression of micro-
metastasis in distant organs or near the primary site in cases with
higher numbers of these CD8
þ T cells. In other words, our data
suggest the presence of a systemic immunosurveillance mechanism
functioning at sites other than primary tumour, and that this
immune activity is in good correlation with the number of CD8
þ
T cells in the primary tumour. Inversely, only insufficient
immune mechanisms would have been functioning in cases
without such intensive CD8
þ T-cell responses. These considera-
tions are consistent with the present observation that the number
of intraepithelial CD8
þ T cells is equally low in the cases that
died of cancer after a curative operation and in patients who
underwent a noncurative operation due to unresectable macro-
metastases. The latter two situations could be similar from the
Table 4 Multivariate analyses by Cox proportional hazard model at 0–2 and 2–10 year observation periods
Late observation period/2–10 years
All patients (N¼272) Curative operation group (N¼260)
Parameters
(risk factor)
Hazard
ratio 95% CI P Parameters
Hazard
ratio 95% CI P
Lymph node
metastasis
a
(positive)
5.6 3.4–9.3 o0.0005 Lymph node
metastasis
a
4.3 2.6–7.4 o0.0005
Distant
metastasis
a
(positive)
18 9.8–32 o0.0005 Invasion pattern 2.6 1.6–4.4 o0.0005
Invasion pattern
(infiltrating)
2.1 1.4–3.2 o0.0005 Intraepithelial
CD8
+ T cells
1.8 1.1–3.0 0.015
Intraepithelial
CD8
+ T cells (low)
1.4 1.0–2.1 0.048
Parameters not significant
b: differentiation (P¼0.24, 0.95), peritumoral TILs (P¼0.20, 0.31), site (P¼0.55, 0.28), MMR proteins (P¼0.99, 0.87), age (P¼0.63, 0.57),
gender (P¼0.72, 0.51), invasion to subserosa
a (P¼0.44, 0.53)
Early observation period/0–2 years
All patients (N¼359) Curative operation group (N¼297)
Parameters Hazard
ratio
95% CI P Parameters Hazard
ratio
95% CI P
Lymph node
metastasis
a
3.3 1.5–7.4 0.003 Invasion pattern 9.9 3.4–29 o0.0005
Distant
metastasis
a
17 7.6–37 o0.0005
Invasion pattern 3.3 1.8–6.0 o0.0005
Peritumoral
TILs
3.6 1.2–11 0.022
Differentiation 2.4 1.1–5.2 0.03
Parameters not significant: intraepithelial CD8+ T cells (P¼0.81), site (P¼0.71),
MMR proteins (P¼0.31), age (P¼0.50), gender (P¼0.76)
Parameters not significant: lymph node metastasis
a (P¼0.12), intraepithelial
CD8+ T cells (P¼0.79), peritumoral TILs (P¼0.10), differentiation (P¼0.90),
site (P¼0.81), MMR proteins (P¼0.74), age (P¼0.90), gender (P¼0.33)
Note that the number of intraepithelial CD8+ T cells was not significant at a 0–2 year observation period. 95% CI¼95% confidence interval of hazard ratio. Bold
face¼parameters significant for patients’ survival after stepdown parameter selection analysis. Italic values stress intraepithelial CD8+ T cells. Data input, the same as in Table 2.
aAnalysed in comparison with stage 1. Death of the primary cancer defined as the event.
bP-values in the parentheses: the former for all patients and the latter for curative
operation group.
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the metastasis.
The higher proliferative activity of intraepithelial CD8
þ T cells
we observed suggests the presence of certain antigenic stimuli to
these lymphocytes (Saiki et al, 1996). Proliferation of central
memory-like CD8
þ T cells has already been confirmed at the site
of inflammation after recall antigenic stimuli (Weninger et al,
2001). Therefore, the proliferating T cells we observed would have
been primed and differentiated in the secondary lymphoid tissues
(i.e. regional lymph nodes), and it is possible to speculate that such
presumable effector cells could home into other organs or tissues,
along with the primary tumour, and suppress micrometastasis.
We also have to consider the possibility that the decrease in the
number of intraepithelial CD8
þ T cells in cases with synchronous
metastasis may be a consequence of systemic immunosuppression
(‘consequence theory’). An incoherence emerges with this
consequence theory; that is, patients who died of cancer after
curative operation, in this scenario, would be expected to have a
higher number of intraepithelial CD8
þ T cells because their
metastatic foci are clinically undetectable, being unable to cause
systemic immunosuppression at the time of operation (cf. Saito
et al, 2000). In reality, our data showed no difference in the
number of T cells between the curative and noncurative groups.
This fact does not support the above ‘consequence theory,’ but
suggests that the decrease of intraepithelial T cells might reflect an
intrinsic lack of systemic antitumour immune responses.
Microsatellite instability (MSI), as a result of frame shift
mutation, is related to a prominent tissue infiltration of T cells
in colorectal cancer (Ishikawa et al, 2003). In the present study,
immunohistochemistry for representative mismatch repair (MMR)
enzymes, an alternative method to detect MSI, revealed no
significant increase of intraepithelial CD8þ T cells in cases with
a loss of MMR eznymes, and no significant increase in right-sided
colon cancer, where the incidence of MSI is high. Therefore,
factors other than MSI may also be important for abundant T-cell
responses in colorectal cancer.
In conclusion, our present study demonstrated the effect of
intraepithelial CD8
þ T cells at longer follow-up periods. This has
lead us to the hypothesis that these CD8
þ T cells may be a
indicator of the presence of systemic immunosurveillance that can
suppress micrometastasis in other sites as well as tumour
suppression in the primary sites. Considering possible clinical
applications, further studies are required to analyse these
presumptive immune effector mechanisms.
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